CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.
Journal Title
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
CURR THER RES CLIN E
ISSN / eISSN
0011-393X / 1879-0313
Aims and Scope
We also encourage the submission of manuscripts presenting preclinical and very preliminary research that may stimulate further investigation of potentially relevant findings, as well as in-depth review articles on specific therapies or disease states, and applied health delivery or pharmacoeconomics.
CTR encourages and supports the submission of manuscripts describing:
• Interventions designed to understand or improve human health, disease treatment or disease prevention;
• Studies that focus on problems that are uncommon in resource-rich countries;
• Research that is "under-published" because of limited access to monetary resources such as English language support and Open Access fees (CTR offers deeply discounted English language editing);
• Republication of articles previously published in non-English journals (eg, evidence-based guidelines) which could be useful if translated into English;
• Preclinical and clinical product development studies that are not pursued for further investigation based upon early phase results.
CTR encourages and supports the submission of manuscripts describing:
• Interventions designed to understand or improve human health, disease treatment or disease prevention;
• Studies that focus on problems that are uncommon in resource-rich countries;
• Research that is "under-published" because of limited access to monetary resources such as English language support and Open Access fees (CTR offers deeply discounted English language editing);
• Republication of articles previously published in non-English journals (eg, evidence-based guidelines) which could be useful if translated into English;
• Preclinical and clinical product development studies that are not pursued for further investigation based upon early phase results.
Subject Area
N/A
CiteScore
3.50
View Trend
CiteScore Ranking
| Category | Quartile | Rank |
|---|---|---|
| Medicine - Pharmacology (medical) | Q3 | #145/272 |
| Medicine - Pharmacology | Q3 | #193/313 |
Web of Science Core Collection
| Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
|---|---|
| - | - |
| Category (Journal Citation Reports 2024) | Quartile |
|---|---|
| MEDICINE, RESEARCH & EXPERIMENTAL | Q3 |
H-index
34
Country/Area of Publication
UNITED STATES
Publisher
Elsevier Inc.
Publication Frequency
Bimonthly
Year Publication Started
1959
Annual Article Volume
36
Open Access
YES
Contact
ELSEVIER, 685 ROUTE 202-206, BRIDGEWATER, USA, NJ, 08807
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started